SKB518

SKB518 · Sichuan Kelun Pharmaceutical Research Institute Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for SKB518, covering 2025-12-05 to 2026-03-04. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SKB518 as Monotherapy or Combination Therapy in Patients With Advanced Gynecological Malignant Tumors [Phase 2]

See pricing